Predictors of Mortality Among Hospitalized COVID-19 Patients at a Tertiary Care Hospital in Ethiopia

References

• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-531986264
   PubMed Web of Science ®Google Scholar
• Pamuk S, Özkan A, Polat B. Epidemiology, pathogenesis, diagnosis and management of COVID-19. Turk J Ear Nose Throat. 2020;30(Supp 1):1–9. doi:10.5606/Tr-ENT.2020.25338
   Google Scholar
• Worldometer. Covid-19 Coronavirus Pandemic. Available from: https://www.worldometers.info/coronavirus/. Accessed November 8, 2021.
   Google Scholar
• Aleem A, Akbar Samad AB, Slenker AK. Emerging Variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19). In: StatPearls. StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC; 2021.
   Google Scholar
• Prevention CfDCa. SARS-CoV-2 Variant Classifications and Definitions; 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html. Accessed November 26, 2021.
   Google Scholar
• Grint DJ, Wing K, Williamson E, et al. Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February. Euro Surveill. 2021;26(11). doi:10.2807/1560-7917.es.2021.26.11.2100256
   Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–2059. doi:10.1001/jama.2020.677532320003
   PubMed Web of Science ®Google Scholar
• Pei G, Zhang Z, Peng J, et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol. 2020;31(6):1157–1165. doi:10.1681/ASN.202003027632345702
   PubMed Web of Science ®Google Scholar
• Bellosta R, Luzzani L, Natalini G, et al. Acute limb ischemia in patients with COVID-19 pneumonia. J Vasc Surg. 2020;72(6):1864–1872. doi:10.1016/j.jvs.2020.04.48332360679
   PubMed Web of Science ®Google Scholar
• Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763–1770. doi:10.1016/S0140-6736(20)31189-232442528
   PubMed Web of Science ®Google Scholar
• Maru EH, Leulseged TW, Hassen IS, et al. Predictors of death in severe COVID-19 patients at millennium COVID-19 care center in Ethiopia: a case-control study. medRxiv. 2020. doi:10.1101/2020.10.07.20205575
   Google Scholar
• Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. doi:10.1016/j.jaci.2020.04.00632294485
   PubMed Web of Science ®Google Scholar
• Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574–1581. doi:10.1001/jama.2020.539432250385
   PubMed Web of Science ®Google Scholar
• Bhaskar S, Rastogi A, Chattu VK, et al. Key strategies for clinical management and improvement of healthcare services for cardiovascular disease and diabetes patients in the Coronavirus (COVID-19) settings: recommendations from the REPROGRAM consortium. Front Cardiovasc Med. 2020;7:112. doi:10.3389/fcvm.2020.0011232613010
   PubMed Web of Science ®Google Scholar
• Bhaskar S, Nurtazina A, Mittoo S, Banach M, Weissert R. Editorial: telemedicine During and Beyond COVID-19. Front Public Health. 2021;9:233. doi:10.3389/fpubh.2021.662617
   Web of Science ®Google Scholar
• Qiu Y, Chen X, Shi W. Impacts of social and economic factors on the transmission of coronavirus disease 2019 (COVID-19) in China. J Popul Econ. 2020;33(4):1127–1172. doi:10.1007/s00148-020-00778-2
   PubMed Web of Science ®Google Scholar
• Coccia M. The relation between length of lockdown, numbers of infected people and deaths of Covid-19, and economic growth of countries: lessons learned to cope with future pandemics similar to Covid-19 and to constrain the deterioration of economic system. Sci Total Environ. 2021;775:145801. doi:10.1016/j.scitotenv.2021.145801
   Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa203457733301246
   PubMed Web of Science ®Google Scholar
• Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111.33306989
   PubMed Web of Science ®Google Scholar
• Bernal JL, Andrews N, Gower C, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373:n1088. doi:10.1136/bmj.n108833985964
   PubMed Web of Science ®Google Scholar
• Hall VJ, Foulkes S, Saei A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. Lancet. 2021;397(10286):1725–1735. doi:10.1016/S0140-6736(21)00790-X33901423
   PubMed Web of Science ®Google Scholar
• Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. N Engl J Med. 2021;385(7):585–594. doi:10.1056/NEJMoa210889134289274
   PubMed Web of Science ®Google Scholar
• GAVI. COVAX vaccine roll-out Ethiopia; 2021.
   Google Scholar
• Fonte L, Acosta A, Sarmiento ME, Ginori M, García G, Norazmi MN. COVID-19 lethality in Sub-Saharan Africa and helminth immune modulation. Front Immunol. 2020;11:2459. doi:10.3389/fimmu.2020.574910
   Web of Science ®Google Scholar
• Diop BZ, Ngom M, Biyong CP, Biyong JNP. The relatively young and rural population may limit the spread and severity of COVID-19 in Africa: a modelling study. BMJ Glob Health. 2020;5(5):e002699. doi:10.1136/bmjgh-2020-002699
   PubMed Web of Science ®Google Scholar
• Gutman JR, Lucchi NW, Cantey PT, et al. Malaria and parasitic neglected tropical diseases: potential syndemics with COVID-19? Am J Trop Med Hyg. 2020;103(2):572. doi:10.4269/ajtmh.20-051632484155
   PubMed Web of Science ®Google Scholar
• Hays R, Pierce D, Giacomin P, Loukas A, Bourke P, McDermott R. Helminth coinfection and COVID-19: an alternate hypothesis. PLoS Negl Trop Dis. 2020;14(8):e0008628. doi:10.1371/journal.pntd.000862832804930
   PubMed Web of Science ®Google Scholar
• Margolin E, Burgers WA, Sturrock ED, et al. Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa. Nat Rev Microbiol. 2020;18(12):690–704. doi:10.1038/s41579-020-00441-332913297
   PubMed Web of Science ®Google Scholar
• Mbow M, Lell B, Jochems SP, et al. COVID-19 in Africa: dampening the storm? Science. 2020;369(6504):624–626. doi:10.1126/science.abd390232764055
   PubMed Web of Science ®Google Scholar
• Alemu Y. Predictors associated with COVID-19 deaths in Ethiopia. Risk Manag Healthc Policy. 2021;13:2769.
   Web of Science ®Google Scholar
• Hiluf Ebuy Abrahaa ZG, Gebrecherkosa T, Kebedea Y, et al. Clinical features and risk factors associated with morbidity and mortality among patients with COVID-19 in northern Ethiopia. Int J Infect Dis. 2021;105:776–783.33741488
   PubMed Web of Science ®Google Scholar
• Chilimuri S, Sun H, Alemam A, et al. Predictors of mortality in adults admitted with COVID-19: retrospective cohort study from New York City. West J Emerg Med. 2020;21(4):779. doi:10.5811/westjem.2020.6.4791932726241
   PubMed Web of Science ®Google Scholar
• World Health Organization. Cilinical managment of COVID-19; May 27, 2020.
   Google Scholar
• Shrestha LB, Pokharel K. Standard operating procedure for specimen collection, packaging and transport for diagnosis of SARS-COV-2. JNMA J Nepal Med Assoc. 2020;58(228):627. doi:10.31729/jnma.526032968304
   PubMed Web of Science ®Google Scholar
• Torretta S, Zuccotti G, Cristofaro V, et al. Diagnosis of SARS-CoV-2 by RT-PCR using different sample sources: review of the literature. Ear Nose Throat J. 2021;100(2_suppl):131S–138S. doi:10.1177/014556132095323132865458
   PubMed Web of Science ®Google Scholar
• Torretta S, Zuccotti G, Cristofaro V, et al. Nonserologic test for COVID‐19: How to manage? Head Neck. 2020;42(7):1552–1554. doi:10.1002/hed.2627032441380
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C, Pujadas E, Wajnberg A, et al. COVID-19: staging of a new disease. Cancer Cell. 2021;38(5):594–597.
   Web of Science ®Google Scholar
• Grippo F, Navarra S, Orsi C, et al. The role of COVID-19 in the death of SARS-CoV-2–positive patients: a study based on death certificates. J Clin Med. 2020;9(11):3459. doi:10.3390/jcm9113459
   Web of Science ®Google Scholar
• Mejía F, Medina C, Cornejo E, et al. Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. PLoS One. 2020;15(12):e0244171. doi:10.1371/journal.pone.024417133370364
   PubMed Web of Science ®Google Scholar
• Assaad S, Zrounba P, Cropet C, Blay J-Y. Consortium O-s. Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study. Br J Cancer. 2021;125(5):658–671. doi:10.1038/s41416-021-01452-434135471
   PubMed Web of Science ®Google Scholar
• Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. 2020;382(25):e102. doi:10.1056/NEJMoa200762132356626
   PubMed Web of Science ®Google Scholar
• Pradhan A, Olsson P-E. Sex differences in severity and mortality from COVID-19: are males more vulnerable? Biol Sex Differ. 2020;11(1):53. doi:10.1186/s13293-020-00330-732948238
   PubMed Web of Science ®Google Scholar
• Du R-H, Liang L-R, Yang C-Q, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55(5):2000524. doi:10.1183/13993003.00524-202032269088
   PubMed Web of Science ®Google Scholar
• Kumar A, Narayan RK, Kulandhasamy M, et al. COVID-19 pandemic: insights into molecular mechanisms leading to sex-based differences in patient outcomes. Expert Rev Mol Med. 2021;23:e7. doi:10.1017/erm.2021.934340720
   PubMed Web of Science ®Google Scholar
• Tian T, Zhang J, Hu L, et al. Risk factors associated with mortality of COVID-19 in 3125 counties of the United States. Infect Dis Pover. 2021;10(1):3. doi:10.1186/s40249-020-00786-0
   Web of Science ®Google Scholar
• Grundy EJ, Suddek T, Filippidis FT, Majeed A, Coronini-Cronberg S. Smoking, SARS-CoV-2 and COVID-19: a review of reviews considering implications for public health policy and practice. Tob Induc Dis. 2020;18:58. doi:10.18332/tid/12478832641924
   PubMed Web of Science ®Google Scholar
• Umnuaypornlert A, Kanchanasurakit S, Lucero-Prisno DEI, Saokaew S. Smoking and risk of negative outcomes among COVID-19 patients: a systematic review and meta-analysis. Tob Induc Dis. 2021;19:09. doi:10.18332/tid/13241133551713
   PubMed Web of Science ®Google Scholar
• Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7). Addiction. 2021;116(6):1319–1368. doi:10.1111/add.1527633007104
   PubMed Web of Science ®Google Scholar
• Patanavanich R, Glantz SA. Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis. BMC Public Health. 2021;21(1):1554. doi:10.1186/s12889-021-11579-x34399729
   PubMed Web of Science ®Google Scholar
• Eakin MN, Neptune E. Smoking and COVID-19: the real deal. Ann Am Thorac Soc. 2021;18(10):1610–1613. doi:10.1513/AnnalsATS.202012-1537PS33645465
   PubMed Web of Science ®Google Scholar
• Dai M, Tao L, Chen Z, et al. Influence of cigarettes and alcohol on the severity and death of COVID-19: a multicenter retrospective study in Wuhan, China. Front Physiol. 2020;11:588553. doi:10.3389/fphys.2020.58855333362576
   PubMed Web of Science ®Google Scholar
• Suzuki A, Efird JT, Redding TS, et al. COVID-19-associated mortality in US Veterans with and without SARS-CoV-2 infection. Int J Environ Res Public Health. 2021;18(16):8486. doi:10.3390/ijerph1816848634444232
   PubMed Web of Science ®Google Scholar
• Heijink IH, Hackett T-L, Pouwels SD. Effects of cigarette smoking on SARS-CoV-2 receptor ACE2 expression in the respiratory epithelium. J Pathol. 2021;253(4):351–354. doi:10.1002/path.560733368245
   PubMed Web of Science ®Google Scholar
• Leung JM, Yang CX, Tam A, et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J. 2020;55(5). doi:10.1183/13993003.00688-2020
   Web of Science ®Google Scholar
• Tantisuwat A, Thaveeratitham P. Effects of smoking on chest expansion, lung function, and respiratory muscle strength of youths. J Phys Ther Sci. 2014;26(2):167–170. doi:10.1589/jpts.26.16724648624
   PubMedGoogle Scholar
• De AK, Tripathi MM. Smoking and lung functions in sportsmen. Br J Sports Med. 1988;22(2):61. doi:10.1136/bjsm.22.2.613167504
   PubMedGoogle Scholar
• Meo SA, AlShehri KA, AlHarbi BB, et al. Effect of Shisha (Waterpipe) smoking on lung functions and fractional exhaled nitric oxide (FeNO) among Saudi young adult Shisha smokers. Int J Environ Res Public Health. 2014;11(9):9638–9648. doi:10.3390/ijerph11090963825233010
   PubMed Web of Science ®Google Scholar
• Frija-Masson J, Debray M-P, Gilbert M, et al. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection. Eur Respir J. 2020;56(2):2001754. doi:10.1183/13993003.01754-202032554533
   PubMed Web of Science ®Google Scholar
• Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol Sin. 2020;35(3):266–271. doi:10.1007/s12250-020-00207-432125642
   PubMed Web of Science ®Google Scholar
• Pasero D, Sanna S, Liperi C, et al. A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis. Infection. 2021;49(5):1055–1060. doi:10.1007/s15010-020-01561-x33331988
   PubMed Web of Science ®Google Scholar
• Fortunato F, Martinelli D, Lo Caputo S, et al. Sex and gender differences in COVID-19: an Italian local register-based study. BMJ Open. 2021;11(10):e051506. doi:10.1136/bmjopen-2021-051506
   Web of Science ®Google Scholar
• Raimondi F, Novelli L, Ghirardi A, et al. Covid-19 and gender: lower rate but same mortality of severe disease in women—an observational study. BMC Pulm Med. 2021;21(1):96. doi:10.1186/s12890-021-01455-033743654
   PubMed Web of Science ®Google Scholar
• Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20(7):442–447. doi:10.1038/s41577-020-0348-832528136
   PubMed Web of Science ®Google Scholar
• Brady E, Nielsen MW, Andersen JP, Oertelt-Prigione S. Lack of consideration of sex and gender in COVID-19 clinical studies. Nat Commun. 2021;12(1):1–6. doi:10.1038/s41467-021-24265-833397941
   PubMed Web of Science ®Google Scholar
• Peckham H, de Gruijter NM, Raine C, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11(1):6317. doi:10.1038/s41467-020-19741-633298944
   PubMed Web of Science ®Google Scholar
• Ueyama H, Kuno T, Takagi H, et al. Gender difference is associated with severity of coronavirus disease 2019 infection: an insight from a meta-analysis. Crit Care Explor. 2020;2(6):e0148–e0148. doi:10.1097/CCE.000000000000014832696011
   PubMedGoogle Scholar
• Saurabh S, Verma MK, Gautam V, et al. Tobacco, alcohol use and other risk factors for developing symptomatic COVID-19 vs asymptomatic SARS-CoV-2 infection: a case-control study from western Rajasthan, India. Trans R Soc Trop Med Hyg. 2021;115(7):820–831. doi:10.1093/trstmh/traa17233444432
   PubMed Web of Science ®Google Scholar
• Marjot T, Moon AM, Cook JA, et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. J Hepatol. 2021;74(3):567–577. doi:10.1016/j.jhep.2020.09.02433035628
   PubMed Web of Science ®Google Scholar
• Fan X, Liu Z, Poulsen KL, et al. Alcohol consumption is associated with poor prognosis in obese patients with COVID-19: a Mendelian randomization study using UK Biobank. Nutrients. 2021;13(5):1592. doi:10.3390/nu1305159234068824
   PubMed Web of Science ®Google Scholar
• Dawson DA, Li T-K, Grant BF. A prospective study of risk drinking: At risk for what? Drug Alcohol Depend. 2008;95(1):62–72. doi:10.1016/j.drugalcdep.2007.12.00718243584
   PubMed Web of Science ®Google Scholar
• Engen PA, Green SJ, Voigt RM, Forsyth CB, Keshavarzian A. The gastrointestinal microbiome: alcohol effects on the composition of intestinal microbiota. Alcohol Res. 2015;37(2):223–236.26695747
   PubMed Web of Science ®Google Scholar
• Rehm J. The risks associated with alcohol use and alcoholism. Alcohol Res Health. 2011;34(2):135–143.22330211
   PubMedGoogle Scholar
• Moon AM, Webb GJ, Aloman C, et al. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry. J Hepatol. 2020;73(3):705–708. doi:10.1016/j.jhep.2020.05.01332446714
   PubMed Web of Science ®Google Scholar
• Reilev M, Kristensen KB, Pottegård A, et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol. 2020;49(5):1468–1481. doi:10.1093/ije/dyaa14032887982
   PubMed Web of Science ®Google Scholar
• Pantea Stoian A, Pricop-Jeckstadt M, Pana A, et al. Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study. Sci Rep. 2020;10(1):21613. doi:10.1038/s41598-020-78575-w33303885
   PubMed Web of Science ®Google Scholar
• Benelli G, Buscarini E, Canetta C, et al. SARS-COV-2 comorbidity network and outcome in hospitalized patients in Crema, Italy. Medrxiv. 2020. doi:10.1101/2020.04.14.20053090
   Google Scholar
• Barbu MG, Thompson RJ, Thompson DC, Cretoiu D, Suciu N. The impact of SARS-CoV-2 on the most common comorbidities–A retrospective study on 814 COVID-19 deaths in Romania. Original Research. Front Med. 2020;7:581. doi:10.3389/fmed.2020.567199
   Web of Science ®Google Scholar
• Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, et al. Predicting mortality due to SARS-CoV-2: a mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico. J Clin Endocrinol Metab. 2020;105(8):2752–2761. doi:10.1210/clinem/dgaa346
   Web of Science ®Google Scholar
• Krishnan S, Patel K, Desai R, et al. Clinical comorbidities, characteristics, and outcomes of mechanically ventilated patients in the State of Michigan with SARS-CoV-2 pneumonia. J Clin Anesth. 2020;67:110005. doi:10.1016/j.jclinane.2020.11000532707517
   PubMed Web of Science ®Google Scholar
• Jordan RE, Adab P, Cheng K. Covid-19: Risk Factors for Severe Disease and Death. British Medical Journal Publishing Group; 2020.
   Google Scholar
• Thakur B, Dubey P, Benitez J, et al. A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. Sci Rep. 2021;11(1):8562. doi:10.1038/s41598-021-88130-w33879826
   PubMed Web of Science ®Google Scholar
• Bhaskar S, Sinha A, Banach M, et al. Cytokine STORM in COVID-19-immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper. Front Immunol. 2020;11:1648. doi:10.3389/fimmu.2020.0164832754159
   PubMed Web of Science ®Google Scholar
• Capra R, De Rossi N, Mattioli F, et al. Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia. Eur J Intern Med. 2020;76:31–35. doi:10.1016/j.ejim.2020.05.00932405160
   PubMed Web of Science ®Google Scholar
• Covino M, De Matteis G, Santoro M, et al. Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years. Geriatr Gerontol Int. 2020;20(7):704–708. doi:10.1111/ggi.1396032516861
   PubMed Web of Science ®Google Scholar
• Díaz-Vélez C, Urrunaga-Pastor D, Romero-Cerdán A, et al. Risk factors for mortality in hospitalized patients with COVID-19 from three hospitals in Peru: a retrospective cohort study. F1000Research. 2021;10:224. doi:10.12688/f1000research.51474.134211701
   PubMedGoogle Scholar
• Friedman J, Calderón-Villarreal A, Bojorquez I, Vera Hernández C, Schriger DL, Tovar Hirashima E. Excess out-of-hospital mortality and declining oxygen saturation: the sentinel role of emergency Medical Services data in the COVID-19 crisis in Tijuana, Mexico. Ann Emerg Med. 2020;76(4):413–426. doi:10.1016/j.annemergmed.2020.07.03533012377
   PubMed Web of Science ®Google Scholar
• Eskandarian R, Sani ZA, Behjati M, et al. Identification of clinical features associated with mortality in COVID-19 patients. medRxiv. 2021. doi:10.1101/2021.04.19.21255715
   Google Scholar
• Grieb P, Swiatkiewicz M, Prus K, Rejdak K. Hypoxia may be a determinative factor in COVID-19 progression. Curr Res Pharmacol Drug Discover. 2021;2:100030. doi:10.1016/j.crphar.2021.100030
   Google Scholar
• Mason RJ. Thoughts on the alveolar phase of COVID-19. m J Physiol Lung Cell Mol Physiol. 2020;319(1):L115–L120. doi:10.1152/ajplung.00126.2020
   PubMed Web of Science ®Google Scholar
• Rizo-Téllez SA, Méndez-García LA, Flores-Rebollo C, et al. The neutrophil-to-monocyte ratio and lymphocyte-to-neutrophil ratio at admission predict in-hospital mortality in Mexican patients with severe SARS-CoV-2 infection (Covid-19). Microorganisms. 2020;8(10):1560. doi:10.3390/microorganisms8101560
   PubMed Web of Science ®Google Scholar
• Cantenys‐Molina S, Fernández‐Cruz E, Francos P, et al. Lymphocyte subsets early predict mortality in a large series of hospitalized COVID‐19 patients in Spain. Clin Exp Immunol. 2021;203(3):424–432. doi:10.1111/cei.1354733187018
   PubMed Web of Science ®Google Scholar
• Wang K, Qiu Z, Liu J, et al. Analysis of the clinical characteristics of 77 COVID-19 deaths. Sci Rep. 2020;10(1):16384. doi:10.1038/s41598-020-73136-733009426
   PubMed Web of Science ®Google Scholar
• Liu J, Li S, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. doi:10.1016/j.ebiom.2020.10276332361250
   PubMed Web of Science ®Google Scholar
• Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5(1):1–3. doi:10.1038/s41392-019-0089-y32296011
   PubMed Web of Science ®Google Scholar
• Li Y, Yang T, Wang S, et al. The value of lymphocyte count in determining the severity of COVID-19 and estimating the time for nucleic acid test results to turn negative. Bosnian J Basic Med Sci. 2021;21(2):235–241. doi:10.17305/bjbms.2020.4868
   Web of Science ®Google Scholar